STAAR Surgical Financials

STAA Stock  USD 28.55  1.87  7.01%   
Based on the analysis of STAAR Surgical's profitability, liquidity, and operating efficiency, STAAR Surgical is performing exceptionally good at this time. It has a great probability to report excellent financial results in December. At present, STAAR Surgical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 37.6 M, whereas Net Debt is projected to grow to (139.8 M). Key indicators impacting STAAR Surgical's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.01380.0132
Sufficiently Up
Slightly volatile
Current Ratio5.845.5615
Sufficiently Up
Slightly volatile
The essential information of the day-to-day investment outlook for STAAR Surgical includes many different criteria found on its balance sheet. An individual investor should monitor STAAR Surgical's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in STAAR Surgical.

Net Income

22.41 Million

  
Understanding current and past STAAR Surgical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of STAAR Surgical's financial statements are interrelated, with each one affecting the others. For example, an increase in STAAR Surgical's assets may result in an increase in income on the income statement.

STAAR Surgical Earnings Geography

Please note, the presentation of STAAR Surgical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STAAR Surgical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STAAR Surgical's management manipulating its earnings.

STAAR Surgical Stock Summary

STAAR Surgical competes with ResMed, West Pharmaceutical, ICU Medical, Merit Medical, and Microbot Medical. STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Staar Surgical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 692 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS8523123052
CUSIP852312305
LocationCalifornia; U.S.A
Business Address25651 Atlantic Ocean
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.staar.com
Phone626 303 7902
CurrencyUSD - US Dollar

STAAR Surgical Key Financial Ratios

STAAR Surgical Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets206.9M257.4M345.8M415.1M488.7M513.1M
Other Current Liab17.7M25.0M30.2M32.6M31.9M33.5M
Net Debt(110.4M)(141.7M)(167.6M)(55.4M)(147.2M)(139.8M)
Retained Earnings(141.8M)(135.9M)(111.4M)(72.4M)(47.4M)(49.7M)
Cash120.0M152.5M199.7M86.5M183.0M192.2M
Net Receivables31.0M35.2M43.5M62.4M98.0M102.9M
Inventory17.1M18.1M17.3M24.2M35.1M36.9M
Other Current Assets315K10.6M10.9M9.5M11.4M12.0M
Total Liab47.0M60.2M87.2M82.7M102.7M107.9M
Total Current Assets174.7M216.4M271.4M312.0M365.3M383.5M
Short Term Debt5.1M7.1M6.8M3.7M8.7M4.5M
Accounts Payable8.1M2.8M8.7M11.6M13.6M14.2M
Common Stock448K464K477K482K488K271.6K
Intangible Assets296K270K218K173K155.7K147.9K
Other Liab8.1M12.4M9.8M3.6M4.2M3.8M
Other Assets4.5M5.6M4.6M5.8M6.6M7.0M
Net Tangible Assets157.8M195.2M256.6M330.2M379.8M398.8M
Capital Surpluse204.9M289.6M304.3M338.2M388.9M240.9M

STAAR Surgical Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense657K2.4M38.02.4M2.8M3.0M
Total Revenue150.2M163.5M230.5M284.4M322.4M338.5M
Gross Profit112.0M118.4M178.6M223.4M252.7M265.3M
Operating Income11.9M6.8M33.3M43.8M28.1M29.5M
Ebit11.9M6.8M33.3M43.8M28.1M29.5M
Ebitda16.1M9.9M37.0M48.3M33.2M34.9M
Cost Of Revenue38.2M45.1M51.8M61.0M69.8M73.3M
Income Before Tax13.0M8.3M31.3M45.8M33.7M35.4M
Net Income14.0M5.9M27.5M39.7M21.3M22.4M
Income Tax Expense(1.0M)2.4M6.8M6.8M12.3M13.0M
Research Development25.3M31.9M33.9M36.0M44.4M46.6M
Tax Provision(1.0M)2.4M6.8M6.8M12.3M13.0M
Net Interest Income988K238K(38K)2.4M7.0M7.3M

STAAR Surgical Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash16.0M32.5M47.3M(113.2M)96.6M101.4M
Free Cash Flow15.6M12.5M30.3M17.6M(3.6M)(3.4M)
Depreciation3.7M3.1M3.6M4.5M5.1M3.0M
Other Non Cash Items2.2M3.4M2.1M2.3M2.2M2.1M
Capital Expenditures10.2M8.4M13.6M18.1M18.2M19.1M
Net Income14.0M5.9M24.5M39.0M21.3M22.4M
End Period Cash Flow120.0M152.5M199.7M86.5M183.0M192.2M
Change To Inventory(950K)(1.4M)66K(7.9M)(14.4M)(13.6M)
Change Receivables(1.9M)(6.0M)(4.5M)(4.0M)(3.6M)(3.8M)
Net Borrowings(2.0M)(515K)(1.6M)(126K)(113.4K)(119.1K)
Change To Netincome8.9M14.1M18.2M21.3M24.5M25.7M
Investments(10.2M)(8.4M)(13.6M)(156.4M)74.3M78.1M

STAAR Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining STAAR Surgical's current stock value. Our valuation model uses many indicators to compare STAAR Surgical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across STAAR Surgical competition to find correlations between indicators driving STAAR Surgical's intrinsic value. More Info.
STAAR Surgical is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about  0.63  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for STAAR Surgical is roughly  1.59 . At present, STAAR Surgical's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the STAAR Surgical's earnings, one of the primary drivers of an investment's value.

STAAR Surgical's Earnings Breakdown by Geography

STAAR Surgical Systematic Risk

STAAR Surgical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. STAAR Surgical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on STAAR Surgical correlated with the market. If Beta is less than 0 STAAR Surgical generally moves in the opposite direction as compared to the market. If STAAR Surgical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one STAAR Surgical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of STAAR Surgical is generally in the same direction as the market. If Beta > 1 STAAR Surgical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in STAAR Surgical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various STAAR Surgical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of STAAR Surgical growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.55

At present, STAAR Surgical's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.

STAAR Surgical November 26, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of STAAR Surgical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of STAAR Surgical. We use our internally-developed statistical techniques to arrive at the intrinsic value of STAAR Surgical based on widely used predictive technical indicators. In general, we focus on analyzing STAAR Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build STAAR Surgical's daily price indicators and compare them against related drivers.

Complementary Tools for STAAR Stock analysis

When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Transaction History
View history of all your transactions and understand their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk